| ARCHETYPE ID | openEHR-EHR-CLUSTER.general_genomics_results.v0 |
|---|---|
| Concept | General genomics results |
| Description | Genomics sequencing result parameters that are calculated once per sequencing run. |
| Use | Use to report general sequencing result parameter determined for the genome by a sequencing test. This archetype is meant to be used in the "Test result" SLOT of the Laboratory test result observation archetype. |
| Misuse | Not to be used to report genetic variants, but only general parameters that are determined once per sequencing run. |
| Purpose | To record general sequencing result parameter of a performed sequencing test. |
| References | |
| Authors | Author name: Aurelie Tomczak Organisation: Institute of Pathology, University Hospital Heidelberg Email: au.tomczak@yahoo.com Date originally authored: 2023-06-12 |
| Other Details Language | Author name: Aurelie Tomczak Organisation: Institute of Pathology, University Hospital Heidelberg Email: au.tomczak@yahoo.com Date originally authored: 2023-06-12 |
| Other Details (Language Independent) |
|
| Keywords | Tumor, cell, content, BRCAness, Microsatellite, instability, (MSI), Tumor, Mutational, Burden, (TMB), per, Mb, Sequencing, result, parameter, Whole, genome, sequencing, Targeted, sequencing, Homologous, recombination, deficiency, (HRD), score |
| Lifecycle | in_development |
| UID | 2b744eb3-b3c8-43b3-9da3-e86649991dd3 |
| Language used | en |
| Citeable Identifier | 1246.145.2029 |
| Revision Number | 0.0.1-alpha |
| items | |
| Tumour cell content (pathologic/histologic) | Tumour cell content (pathologic/histologic): Tumour cell content determinded by pathologic/histologic methods. Choice of:
|
| Tumour cell content (bioinformatic) | Tumour cell content (bioinformatic): Tumour cell content determinded by bioinformatic methods. Choice of:
|
| Microsatellite instability (MSI) | Microsatellite instability (MSI): Microsatellite instability (MSI). min: >=0; max: <=2 |
| MSI classification | MSI classification: Classification of the Microsatellite instability (MSI). e.g. MSS, MSI low or MSI high. Choice of:
|
| Tumor Mutational Burden (TMB) per Mb | Tumor Mutational Burden (TMB) per Mb: Tumor Mutational Burden (TMB) per Megabase. |
| TMB classification | TMB classification: Classification of Tumor Mutational Burden (TMB) per Megabase. e.g. low, intermediate or high. Choice of:
|
| BRCAness | BRCAness: BRCAness is defined as a phenotypic copy of germline BRCA mutations. Choice of:
|
| Homologous recombination deficiency (HRD) score | Homologous recombination deficiency (HRD) score: The Homologous recombination deficiency (HRD) score is the sum of loss-of-heterozygosity (LOH), telomeric allelic imbalance (TAI), and large-scale state transitions (LST). |
| HRD classification | HRD classification: Classification of the Homologous recombination deficiency (HRD) score. e.g. low, intermediate or high. |
| Further results | Further results: Cluster to include additional result parameters not already defined above. |
| Name | Name: Parameter name. Choice of:
|
| Value | Value: Parameter value. |
| Value classification | Value classification: Classification of value. e.g. low, intermediate or high. Choice of:
|
| Qualitative interpretation | Qualitative interpretation: Qualitative parameter interpretation, if applicable. |
| Other contributors | |
| Translators |